Summary
- Current Price
- As of today, ACAD price is $21.97, down -2.53% on
- Current Price All-Time High
- ACAD price is currently -62.59% below its historical high of $58.72 set on
- Market Cap
- ACAD current market cap is $4B, up +29.64% over the past 365 days
- PE Ratio
- ACAD current PE ratio is 9.60
- Revenue
- ACAD current annual revenue is $1.07B, up +11.87% year-over-year
- Next Earnings
- The next earnings release for ACAD is on
Profile
| Metric | Value |
|---|---|
| Full Name | ACADIA Pharmaceuticals Inc. |
| Ticker | NASDAQ: ACAD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | acadia.com |
| Employees | 653 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.97 | |
| Price, 1D Change | -2.53% | |
| $4B | ||
| - | ||
| 9.60 | ||
| 0.86 | ||
| $1B | ||
| Revenue, 1Y Change | +11.87% | |
| $2.30 | ||
| EPS, 1Y Change | +69.05% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.30 | ||
| EPS Estimate | N/A | $0.50 |
| EPS Est. Change | N/A | -78.42% |
| $1.07B | ||
| Revenue Estimate | N/A | $1.25B |
| Revenue Est. Change | N/A | +16.54% |
| Current Price | $21.97 | |
| Price Target | - | $32.50 |
| Price Tgt. Change | - | +47.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.74 | $1.36 | +84.77% | |
| $0.81 | $2.30 | +185.11% | |
| $0.50 | N/A | -78.42% | |
| $0.90 | N/A | -60.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $969.41M | $957.80M | -1.20% | |
| $1.08B | $1.07B | -0.86% | |
| $1.25B | N/A | +16.54% | |
| $1.39B | N/A | +30.09% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.97 | |
| $23.79 | ||
| SMA 200 vs Price | +8.28% | |
| $24.86 | ||
| SMA 50 vs Price | +13.15% | |
| 0.86 | ||
| $1.03 | ||
| 38.01 | ||
| 48.56% | ||
| 47.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.07B | ||
| $2.30 | ||
| $982.51M | ||
| 91.69% | ||
| $104.81M | ||
| 9.78% | ||
| $391.00M | ||
| 36.49% | ||
| $116.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 3.83 | ||
| 3.71 | ||
| - | ||
| 5 | ||
| 6.51 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 9.60 | ||
| 3.47 | ||
| 3.03 | ||
| 25.30 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.23B | ||
| $819.69M | ||
| $1.56B | ||
| $1.06B | ||
| $336.81M | ||
| $277.11M | ||
| $40.55M | ||
| $11.63M | ||
| $10.90M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $680.51M | ||
| $877.70M | ||
| $99.89M | ||
| $0.00 | ||
| $11.76M | ||
| $0.00 | ||
| -$252.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $109.84M | ||
| -$302.56M | ||
| $49.88M | ||
| $103.53M | ||
| $6.31M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| TD Cowen | → | |
| Stifel | → | |
| RBC Capital | → | |
| Citizens | → | |
| Wolfe Research | ||
| Mizuho | → | |
| Oppenheimer | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ACAD
FAQ
What is the ticker symbol for ACADIA Pharmaceuticals Inc.?
The ticker symbol for ACADIA Pharmaceuticals Inc. is NASDAQ:ACAD
Does ACADIA Pharmaceuticals Inc. pay dividends?
No, ACADIA Pharmaceuticals Inc. does not pay dividends
What sector is ACADIA Pharmaceuticals Inc. in?
ACADIA Pharmaceuticals Inc. is in the Healthcare sector
What industry is ACADIA Pharmaceuticals Inc. in?
ACADIA Pharmaceuticals Inc. is in the Biotechnology industry
What country is ACADIA Pharmaceuticals Inc. based in?
ACADIA Pharmaceuticals Inc. is headquartered in United States
When did ACADIA Pharmaceuticals Inc. go public?
ACADIA Pharmaceuticals Inc. initial public offering (IPO) was on May 27, 2004
Is ACADIA Pharmaceuticals Inc. in the S&P 500?
No, ACADIA Pharmaceuticals Inc. is not included in the S&P 500 index
Is ACADIA Pharmaceuticals Inc. in the NASDAQ 100?
No, ACADIA Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is ACADIA Pharmaceuticals Inc. in the Dow Jones?
No, ACADIA Pharmaceuticals Inc. is not included in the Dow Jones index
When was ACADIA Pharmaceuticals Inc. last earnings report?
ACADIA Pharmaceuticals Inc.'s most recent earnings report was on February 25, 2026
When does ACADIA Pharmaceuticals Inc. report earnings?
The next expected earnings date for ACADIA Pharmaceuticals Inc. is May 6, 2026
Data Sources & References
- ACAD Official Website www.acadia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1070494/000119312526071674/0001193125-26-071674-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1070494/000119312526071674/0001193125-26-071674-index.htm
- ACAD Profile on Yahoo Finance finance.yahoo.com/quote/ACAD
- ACAD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acad